Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
OConnell Daniel Joseph
Chief Executive Officer at Acumen Pharmaceuticals. Filing since 19 Jan 2024.
CIK 0001865136
Company
Date
Role
Action
Shares
Amount
Of holding
ABOS
Acumen Pharmaceuticals, Inc.
22 Jan 2026
Chief Executive Officer
Sold at will
2,689
$5.07K
0.3%
ABOS
Acumen Pharmaceuticals, Inc.
21 Jan 2026
Chief Executive Officer
Sold at will
9,346
$16.93K
1.0%
ABOS
Acumen Pharmaceuticals, Inc.
12 Jan 2026
Chief Executive Officer
Sold at will
5,388
$9.31K
0.9%
ABOS
Acumen Pharmaceuticals, Inc.
9 Jan 2026
Chief Executive Officer
Sold at will
12,941
$22.83K
2.1%
ABOS
Acumen Pharmaceuticals, Inc.
8 Jan 2026
Chief Executive Officer
Sold at will
8,143
$14.82K
1.3%
ABOS
Acumen Pharmaceuticals, Inc.
7 Jan 2026
Chief Executive Officer
Sold at will
37,755
$74.98K
5.7%
ABOS
Acumen Pharmaceuticals, Inc.
6 Jan 2026
Chief Executive Officer
Sold at will
5,102
$10.03K
0.8%
ABOS
Acumen Pharmaceuticals, Inc.
5 Jan 2026
Chief Executive Officer
Sold at will
4,649
$9.16K
0.7%
ABOS
Acumen Pharmaceuticals, Inc.
21 Jan 2025
Chief Executive Officer
Sold on a plan
12,619
$20.10K
1.9%
ABOS
Acumen Pharmaceuticals, Inc.
3 Jan 2025
Chief Executive Officer
Sold on a plan
47,778
$87.87K
9.5%
ABOS
Acumen Pharmaceuticals, Inc.
19 Jan 2024
President and CEO
Sold on a plan
15,200
$52.75K
2.9%
11 decisions on file.
